Viagra Connect® is a treatment for Erectile Dysfunction (ED) containing 50mg of sildenafil. It is available to patients over 18 years with ED directly from pharmacy without a doctor’s prescription.
To save you time when visiting your local Hickey’s Pharmacy, complete the form (see link below).
Viagra Connect® as a treatment for Erectile Dysfunction
Erectile dysfunction (ED) is the inability to achieve or maintain an erection sufficient to have sex.
Erection problems can put a strain on relationships. They can also be a warning sign of a health condition or disease you might not be aware of. That’s why it’s important to take action and find a solution for your ED.
Daily life can sometimes get in the way of your sex life. When it does, Viagra Connect is here to help.
Who it’s for: Viagra Connect is for adult men (over 18 years of age) who have erection problems (EPs) – what doctors might call erectile dysfunction (ED).
Who it isn’t for: If you are a woman, a man under 18, or do not have EPs, then Viagra Connect isn’t the right treatment for you.
Where you buy it: From our trusted partner ChemistDirect, from other online pharmacies, and from your local pharmacy. No prescription needed.
Are you taking other medicines? Some medicines can interact with Viagra Connect, so you’ll be asked what else you might be taking before you can buy it.
Do you have any other health conditions? Some men will have issues with their health that make Viagra Connect unsuitable for them. This is why you’ll be asked a few straightforward questions about your health before you can buy it.
Viagra Connect is a treatment for Erectile Dysfunction (ED) – the inability to achieve or maintain an erection sufficient to have sex.
Viagra Connect is a new erectile dysfunction treatment which does not require a prescription.
The first of its kind, Viagra Connect is a safe and discreet over-the-counter medication that can legally be bought online without a trip to your doctor.
We need to ensure that this medicine is suitable for the person it is intended for. Therefore, it should only be purchased by the person taking it.
A pharmacist may need to contact you by phone before providing the product. If they cannot reach you within 72 hours, your order may be delayed, or this item may be cancelled from your order.
Please ensure your contact details are correct before ordering this medicine.Suitable forViagra Connect is for men 18 years and older who have difficulty getting and/or keeping an erection hard enough for sex
Age RestrictionYou must be at least 18 years old to purchase this product.
Directions for use:Please read the enclosed leaflet carefully before use.
• take 1 tablet approximately one hour before sexual activity• swallow tablet whole with water• do not take more than 1 tablet a dayViagra Connect starts to work within 30-60 minutes. You may take it up to 4 hours before sexual activity.
Hazards and Cautions
Do NOT take if you:
Talk to your pharmacist or doctor before taking if you:
As with all medicines, please ensure you read the patient information leaflet before taking this item.
Nguyen Thi NhongDear I. M. C.:
I had been taking a low dose of sildenafil for a couple of weeks. I started feeling very weak, felt a bit light headed, started having some heart palpitations. I took a tablet a couple of hours before sex and felt very weak. I have also taken nitrates for chest pain. I am not sure why I am feeling very weak. I am also not sure why I have not been getting an erection for about 4 hours now. I have had some chest pains, palpitations, dizziness and fainting. I have also taken riociguat for high blood pressure. My blood pressure is high and my heart is weak. I have had some side effects from riociguat. I am not sure why sildenafil is helping. I am also not sure why I have taken it and what it is that is helping. It does help but I am worried that sildenafil could just as easily be causing my heart to pump too fast. I am also worried that my heart will beat too fast. I also have had some side effects from riociguat. I am worried that sildenafil could just as easily be causing my heart to pump too fast.
A Brazilian company, the Brazilian Pharmaceutical Group, has announced that it is adding two new products that it expects to be launched as a result of the Brazilian Pharmaceutical Agency’s new strategic initiative.
The new products, which are currently under way in the country, include a product aimed at lowering the risk of erectile dysfunction, which will be sold in Brazil.
The product, “Sildenafil Citrate and Its Derived Product,” is the first product in Brazil to be launched as a result of the new initiative.
The company’s first product is already available in Brazil for the first time, which is expected to take the form of a capsule, which is made in the same way as the erectile dysfunction drug Viagra. The company has also launched a generic version of the product in Brazil.
Brazilian Pharmaceuticals, which manufactures the erectile dysfunction drug, is among the biggest pharmaceutical companies in the country. It is the country’s second-largest pharmaceutical company.
The company is also the second pharmaceutical company in Brazil to launch new products under the new initiative.
The new products will include a new product aimed at improving sexual function and a generic product aimed at improving the overall health of patients.
The companies will collaborate to develop new medicines for diseases affecting sexual function, such as erectile dysfunction.
A press release from the company is available here:
This press release is available on the company's website:The Brazilian Pharmaceutical Agency (BPA) has been working with the Brazilian Pharmaceutical Companies in the past three years to establish a new strategic initiative to expand the availability of erectile dysfunction drugs in the country. The new initiative aims to help the country’s pharmaceutical industry make accessible medicines to the people.
BPA has recently signed a new agreement with the Brazilian government to implement the new initiative. The initiative will be available in Brazil for the first time at a price of 20,000 USD.
The new initiative will be launched at an affordable price in Brazil, with a 100% price guarantee from the Brazilian government. The price will be applicable up to four business days after the announcement of the initiative. The prices of the two new products will be determined by the Brazilian Pharmaceutical Agency.
The new products are the results of the Brazilian Pharmacy Industry Regulatory Authority (ABRO) initiative, which has been working with the Brazilian Pharmaceutical Agency since it started working on the project in November 2017.
The two products, which are currently under way in Brazil, are the “Sildenafil Citrate” and “Viagra,” which are the active ingredients in the erectile dysfunction drug.
The company is in the process of expanding its global presence in the country and will now have the capacity to produce the two products.
BPA has also recently partnered with the Brazilian government to provide health and development services and to conduct public health assessments for the public.
The company is also planning to launch a generic version of Viagra, and the products will be made in the country for a price of 50,000 USD.
The company is also working with the Brazilian Pharmaceutical Companies to establish a new initiative to improve sexual function.
The Brazilian Pharmaceutical Agency (BPA) has been working with the Brazilian government to establish a new initiative to improve sexual function in Brazil. The initiative aims to help the country’s pharmaceutical industry make accessible medicines to the people.
The two products are the results of the Brazilian Pharmacy Industry Regulatory Authority (ABRO) initiative, which has been working with the Brazilian Pharmacy Companies since it started working on the project in November 2017.
US–A
In a
, the US federal health department announced that it will have begun its own erectile dysfunction (ED) program in Mexico.
According to the
, the Department of Health and Human Services of the US will help to ensure the safety of those who suffer from sexual dysfunction.
In the latest issue of the
, the FDA released a safety profile of a drug called Viagra, which treats erectile dysfunction, including premature ejaculation.
The drug is used to treat both male and female sexual dysfunction and has been approved to treat conditions such as the male sexual dysfunctions. But its safety has been under the spotlight. While it was announced on Friday that the drug is approved to treat a condition called hypoactive sexual desire disorder, it was also announced that it may also be used to treat
, which affects a person’s ability to have or maintain a healthy sexual relationship.
The drug’s safety has been under the spotlight since it was first approved for this purpose.
A report published by the
in November found that the drug could increase the risk of serious cardiovascular events such as heart attack, stroke and blood clots. The drug was also linked to an increased risk of heart attack in women and a stroke in men.
The FDA has also warned that its drug may increase the risk of developing a rare inherited eye disorder called
of eye disease.
, it has been linked to an increased risk of
.
According to the report, the drug has been linked to an increased risk of
in people with certain genetic conditions. It was also linked to a rare inherited eye disorder called
, and was linked to an increased risk of
The report’s release is part of a larger
that is being reported in the
in
The report also detailed how the
has linked the drug to an increased risk of
, and has also detailed
, which is linked to a rare inherited eye disease.
“Our report is not only about the use of the drug in treating men with male sexual dysfunction, it is about the use of
to treat
,” said Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research. “It’s also about the use of the drug in men with
and the potential for cardiovascular events, such as heart attacks or strokes.”
According to the report, it has been linked to an increased risk of
, and
, which is linked to
“It’s important for health officials to understand that
and
are associated with a number of other problems, including
, and that there is a potential for a potentially dangerous reaction of men to
,” said Woodcock.
The
has also highlighted the potential for
to cause
In addition, the report noted that the drug has been linked to an increased risk of
and that
, which are linked to